HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CBD Pollinating New Beauty Categories With Cannabis Cachet: Sunscreens, Deodorants And More

Executive Summary

Cannabidiol (CBD) is spreading from therapeutic skin care to deodorants, sunscreens and makeup products as companies race to meet consumer demand despite regulatory uncertainties and potential legal pitfalls.

You may also be interested in...



Eldest Kardashian Sis Launching CBD Serum With Hora Skincare

Kourtney of the “Keeping Up With” clan has partnered with Hora Skincare to launch Hyaluronic Halo + CBD Serum. Announced 6 September, the $50 product will be available exclusively through Kardashian’s Poosh lifestyle platform.

CBD Suits Challenge ‘THC-Free’ Claims After Users Fail Drug Tests; Plaintiffs Bar May Just Be Warming Up

Attorneys are warning CBD product marketers to be on guard for litigation challenging the authenticity of their claims, the safety of their products and other aspects of their businesses. So far, suits of this nature have been limited in the US, but the few known cases could be harbingers of a larger wave to come.

CBD Beauty Claims Based On Third-Party Studies Could Be Litigation Targets – Venable Attorney

There’s a growing body of scientific evidence linking cannabidiol to benefits of interest to beauty industry players, but if a company’s CBD ingredient differs from the substance studied, that could be grounds for a false-advertising complaint. Venable partner Todd Halpern discusses.

Related Content

Topics

UsernamePublicRestriction

Register

RS149176

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel